Jefferies Group’s Aerie Pharmaceuticals AERI Stock Holding History

Jefferies Group’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$35.7M	Hold	2,361,000	–	–	0.3%	58
2022 Q2	$17.7M	Hold	2,361,000	–	–	0.15%	104
2022 Q1	$21.5M	Sell	2,361,000 -15,000	-0.6%	-$116K	0.14%	112
2021 Q4	$16.7M	Buy	+2,376,000	New	+$24.9M	0.1%	170
2020 Q3	–	Sell	-25,000	Closed	-$369	–	1618
2020 Q2	$369	Buy	+25,000	New	+$370K	﹤0.01%	977
2020 Q1	–	Sell	-102,077	Closed	-$2.47M	–	2814
2019 Q4	$2.47M	Buy	+102,077	New	+$2.11M	0.02%	924
2018 Q3	–	Sell	-1,400	Closed	-$95K	–	2838
2018 Q2	$95K	Buy	+1,400	New	+$78.3K	﹤0.01%	2143

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Jefferies Group's AERI Position: Q3 2022 in Review

Jefferies Group held its Aerie Pharmaceuticals (AERI) position steady in Q3 2022 at 2,361,000 shares worth $35.7M. The position accounts for 0.3% of the portfolio, ranked #58.

Jefferies Group first reported a position in AERI in Q2 2018 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

Jefferies Group held 2,361,000 shares of Aerie Pharmaceuticals worth $35.7M as of Q3 2022.
Jefferies Group left its Aerie Pharmaceuticals share count unchanged in Q3 2022.
Aerie Pharmaceuticals made up 0.3% of Jefferies Group's portfolio in Q3 2022, its #58 holding.
Jefferies Group first reported a position in Aerie Pharmaceuticals in Q2 2018 and has held it in 7 quarters since.
156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.